stockaxis

Hikal Ltd

Pharmaceuticals & Drugs - Global

Stocks on The Move

CMP
Rs. 405.00
Rating:
Buy
April 11, 2025

Stock Info

BSE
524735
NSE
HIKAL
Sector
Pharmaceuticals & Drugs - Global
Face Value (Rs)
2
Equity Capital (Rs cr)
25.00
Mkt Cap (Rs cr)
4,732.28
52w H/L (Rs)
464.75 - 267.25
Avg Daily Vol (BSE+NSE)
135,312

Shareholding Pattern

(as on 31-Dec)
%
Promoter
68.85
FIIs
5.70
DIIs
3.80
Public & Others
21.65
Source: Ace equity, stockaxis Research

Price performance

Return (%)
1m
3m
12m
Absolute
3.38
3.27
29.49
Sensex
-0.36
-4.86
-1.12
Source: Ace equity, stockaxis Research

Indexed Stock Performance

Hikal Ltd Sensex
Hikal Ltd
Source: Ace equity, stockaxis Research

Breaking Out of Consolidation

Hikal Ltd

The price has remained above the 200-day simple moving average (SMA), which typically serves as a strong support level during an uptrend. When the 21 exponential moving average (EMA) is above the 50 SMA, and the 50 SMA is above the 200 SMA, it indicates a bullish trend, showing that the stock is gaining upward momentum. Recent price movements have shown higher highs and higher lows, which is another positive indicator. The relative strength index (RSI) is currently above 50, reinforcing the bullish momentum. There are no significant signs of bearish divergence. Additionally, there has been a clear rise in volume on bullish candles, indicating strong buying interest. Volume increases during recent price rises suggest accumulation, while low volume during consolidation phases confirms healthy accumulation.

Hence, we recommend buying the stock at cmp while any dip around 395-397 can be utilized to average with a stop loss below Rs.370 for target of Rs.475.

Consolidated Financial Statements